EGFR Sensitive Mutation: Clinical Trials

1 trial for EGFR Sensitive Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow EGFR Sensitive Mutation: new trials by email Literature Review of EGFR Sensitive Mutation trials Research Report on EGFR Sensitive Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody
Anlotinib, Penpulimab - Lung Cancer, TKI Resistance
Phase 3UnknownDegan Lu522023-09-012023-09-21

Narrower conditions

Lung Neoplasms (1)

Broader conditions

Lung Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

anlotinib (1)  ·  penpulimab (1)

Sponsors

Degan Lu (1)

Results publications

PMID 27413711, PMID 28486985, PMID 29438373, PMID 30419091, PMID 33433946, PMID 33791214, PMID 34327136, PMID 35875118